Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
Clinical and Molecular Hepatology
;
: 183-187, 2016.
Article
Dans Anglais
| WPRIM
| ID: wpr-46324
ABSTRACT
Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Antiviraux
/
ADN viral
/
Varices oesophagiennes et gastriques
/
Virus de l'hépatite B
/
Réaction de polymérisation en chaîne
/
Échographie
/
Hépatite B chronique
/
Abdomen
/
Guanine
/
Cirrhose du foie
Type d'étude:
Etude diagnostique
Limites du sujet:
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Clinical and Molecular Hepatology
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS